Skip to main content

Table 4 Biomarkers in relation to their predictive value for achieving a pathological complete response: multivariate logistic regression in 194 patients

From: Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast

 

Odds ratio

95% CI

p Value

Ki-67

0.43

0.11 to 1.61

0.208

HER2

4.05

0.87 to 18.95

0.076

p53

0.69

0.22 to 2.16

0.527

bcl-2

9.39

1.17 to 75.18

0.035

  1. HER2, human epidermal growth factor receptor 2.
Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us